Company intelligence / Profile preview

Hangzhou Zede Pharmaceutical Technology

Hangzhou, Zhejiang, Chinapitchbook.com ↗

Ownership: Private
Development stage: Other

Overview

Hangzhou Zede Pharmaceutical Technology is developing innovative small molecule therapies with a focus on iron chelation. Its lead candidate is an oral iron chelator for the treatment of thalassemia, which has completed Phase I and is advancing to Phase II clinical trials. The company also has preclinical research underway targeting myelodysplastic syndrome and Parkinson’s disease. It has received multiple awards for innovation and maintains strategic partnerships with leading academic institutions.

Therapeutic areas: HematologyNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Resonance Health Limited (for clinical trial collaboration on liver iron concentration assessment technology)College of Pharmaceutical Science at Zhejiang UniversityKing’s College London

Beyond the preview

Go deeper on Hangzhou Zede Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Zede Pharmaceutical Technology.

Explore the full profile